HeyJaredHeidi Splete
- Indexed articles, last 90 days
- 32
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Traction Alopecia: Wig-Induced Cases in Children (opens the original)
Read excerpt
Wearing wigs for vigorous Irish dancing was the source of traction alopecia in several young girls, according to a recently published case series, highlighting another cause of hair loss that has also been associated with tight braids, ponytails, and buns. Traction alopecia associated with high-tension hairstyles is a known cause of hair loss in adults but is not widely reported in children, especially as a result of wig-wearing, wrote Sara N. Bilimoria, MD, a dermatology resident at the Medical
JAK Inhibitor for Alopecia Approved for Younger Age Group (opens the original)
Read excerpt
The FDA has approved baricitinib for the treatment of severe alopecia areata (AA) in patients aged 12 years and older, according to a press release from the manufacturer. The approval extends the use of baricitinib (Olumiant, Eli Lilly), a JAK inhibitor, to younger patients. The once-daily pill was initially approved for adults with moderate-to-severe rheumatoid arthritis in 2018 and subsequently approved for adults with severe AA in 2022. It also was approved in 2022 to treat COVID in certain h
Psoriasis: Promising Data Reported for IL-23p19 Inhibitor (opens the original)
Read excerpt
Nearly two thirds of adults with moderate-to-severe plaque psoriasis met the primary endpoint of a Psoriasis Area Severity Index (PASI) score of 100 at 28 weeks, after receiving treatment with a new monoclonal antibody, according to a press release from Oruka Therapeutics, developer of the medication. EVERLAST-A, an ongoing randomized, double-blind, placebo-controlled phase 2a study, is evaluating the safety, efficacy, and pharmacokinetics of ORKA-001, an interleukin (IL)-23p19 monoclonal antibo
Experts Urge FDA to Approve Testosterone Products for Women (opens the original)
Read excerpt
Use of testosterone by women, especially menopausal women, continues to expand, despite the lack of long-term safety data and the lack of an approved product for women in the US, according to experts. During a public workshop on testosterone use in menopausal women hosted by the FDA Office of Women’s Health and the Center for Drug Evaluation and Research, clinicians and researchers reviewed the current evidence and called on the FDA for additional research and expanded approvals of testosterone
Wastewater May Work for STI Monitoring (opens the original)
Read excerpt
The bacteria that cause chlamydia were identified in up to 88% of wastewater samples in Washington State, which supports the potential of wastewater-based epidemiology to monitor pathogens causing sexually transmitted infections (STIs), according to a new study. STIs are not routine candidates for wastewater monitoring in the US, but their significant health burden at the national and local level has prompted interest in improving surveillance, according to corresponding author Erica Fuhrmeister
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.